Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion type Assertion NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_head.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion description "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_provenance.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion evidence source_evidence_literature NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_provenance.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion SIO_000772 24571711 NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_provenance.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion wasDerivedFrom befree-2016 NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_provenance.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion wasGeneratedBy ECO_0000203 NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_provenance.